Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer

被引：0
|
作者：
Zhao, Ruiying [1 ]
Xiang, Chan [1 ]
Zhu, Lei [1 ]
Shao, Jinchen [1 ]
Zhao, Jikai [1 ]
Guo, Lianying [1 ]
Ma, Shengji [1 ]
Yu, Anbo [1 ]
Han, Yuchen
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1977
引用
收藏
页码：1833 / 1834
页数：2
相关论文
共 50 条
  • [31] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
    Fang, Shu
    Wang, Zhehai
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611
  • [32] EGFR Mutations in Non-Small-Cell Lung Cancer Find, Divide, and Conquer
    Morgensztern, Daniel
    Politi, Katerina
    Herbst, Roy S.
    [J]. JAMA ONCOLOGY, 2015, 1 (02) : 146 - 148
  • [33] Expression of ErbB2 and ErbB3 in Non-Small Cell Lung Cancer
    Salcedo, M. T.
    Montero, M. A.
    Hernandez-Losa, J.
    Teixido, C.
    Allende, H.
    Felip, E.
    Murtra-Garrell, N.
    Pallisa, E.
    Canela, M.
    Ramon y Cajal, S.
    Tallada, N.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 489A - 489A
  • [34] Expression of ErbB2 and ErbB3 in Non-Small Cell Lung Cancer
    Salcedo, M. T.
    Montero, M. A.
    Hernandez-Losa, J.
    Teixido, C.
    Allende, H.
    Felip, E.
    Murtra-Garrell, N.
    Pallisa, E.
    Canela, M.
    Ramon y Cajal, S.
    Tallada, N.
    [J]. MODERN PATHOLOGY, 2012, 25 : 489A - 489A
  • [35] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    Gazdar, A. F.
    [J]. ONCOGENE, 2009, 28 : S24 - S31
  • [36] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    A F Gazdar
    [J]. Oncogene, 2009, 28 : S24 - S31
  • [37] Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Igawa, Satoshi
    Ryuge, Shiichiro
    Ichinoe, Masaaki
    Nakashima, Hiroyasu
    Otani, Sakiko
    Nakahara, Yoshiro
    Fukui, Tomoya
    Sasaki, Jiichiro
    Kubota, Masaru
    Katagiri, Masato
    Murakumo, Yoshiki
    Satoh, Yukitoshi
    Sato, Yuichi
    Masuda, Noriyuki
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (1-2) : 7 - 13
  • [38] ERBB2 kinase domain mutation in the lung squamous cell carcinoma
    Lee, Jong Woo
    Soung, Young Hwa
    Kim, Su Young
    Nam, Suk Woo
    Park, Won Sang
    Wang, Young Pil
    Jo, Keon Hyun
    Moon, Seok Whan
    Song, Sang Yong
    Lee, Jung Young
    Yoo, Nam Jin
    Lee, Sug Hyung
    [J]. CANCER LETTERS, 2006, 237 (01) : 89 - 94
  • [39] Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer
    Na, Im Il
    Rho, Jin Kyung
    Choi, Yun Jung
    Kim, Cheol Hyeon
    Koh, Jae Soo
    Ryoo, Baek-Yeol
    Yang, Sung Hyun
    Lee, Jae Cheol
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (03) : 393 - 399
  • [40] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
12345